Inserm U986, Hôpital Bicêtre-Paris-Sud, Le Kremlin-Bicêtre, France.
Hum Mutat. 2013 Aug;34(8):1172-80. doi: 10.1002/humu.22352. Epub 2013 May 28.
Most patients with pseudohypoparathyroidism type 1b (PHP-1b) display a loss of imprinting (LOI) encompassing the GNAS locus resulting in PTH resistance. In other imprinting disorders, such as Russell-Silver or Beckwith-Wiedemann syndrome, we and others have shown that the LOI is not restricted to one imprinted locus but may affect other imprinted loci for some patients. Therefore, we hypothesized that patients with PHP-1b might present multilocus imprinting defects. We investigated, in 63 patients with PHP-1b, the methylation pattern of eight imprinted loci: GNAS, ZAC1, PEG1/MEST, ICR1, and ICR2 on chromosome 11p15, SNRPN, DLK1/GTL2 IG-DMR, and L3MBTL1. We found multilocus imprinting defects in four PHP-1b patients carrying broad LOI at the GNAS locus (1) simultaneous hypermethylation at L3MBTL1 differentially methylated region 3 (DMR3), and hypomethylation at PEG1/MEST DMR (n = 1), (2) hypermethylation at the L3MBTL1 (DMR3) (n = 1) and at the DLK1/GTL2 IG-DMR (n = 1), and (3) hypomethylation at the L3MBTL1 DMR3 (n = 1). We suggest that mechanisms underlying multilocus imprinting defects in PHP-1b differ from those of other imprinting disorders having only multilocus loss of methylation. Furthermore, our results favor the hypothesis of "epidominance", that is, the phenotype is controlled by the most severely affected imprinted locus.
大多数 1b 型假性甲状旁腺功能减退症(PHP-1b)患者表现出包含 GNAS 基因座的印迹丢失(LOI),导致甲状旁腺素抵抗。在其他印迹疾病中,如 Russell-Silver 或 Beckwith-Wiedemann 综合征,我们和其他人已经表明,LOI 不仅限于一个印迹基因座,而是可能影响其他印迹基因座的一些患者。因此,我们假设 PHP-1b 患者可能存在多基因座印迹缺陷。我们研究了 63 例 PHP-1b 患者的 8 个印迹基因座(GNAS、ZAC1、PEG1/MEST、ICR1 和 ICR2 位于 11p15 染色体上)、SNRPN、DLK1/GTL2 IG-DMR 和 L3MBTL1 的甲基化模式。我们发现,携带 GNAS 基因座广泛 LOI 的 4 例 PHP-1b 患者存在多基因座印迹缺陷:(1)L3MBTL1 差异甲基化区 3(DMR3)的同时过度甲基化和 PEG1/MEST DMR 的低甲基化(n = 1),(2)L3MBTL1(DMR3)(n = 1)和 DLK1/GTL2 IG-DMR(n = 1)的过度甲基化,以及(3)L3MBTL1 DMR3 的低甲基化(n = 1)。我们认为,PHP-1b 中多基因座印迹缺陷的机制与仅存在多基因座去甲基化的其他印迹疾病不同。此外,我们的结果支持“优势表型”假说,即表型由受影响最严重的印迹基因座控制。